HOME Research Insight Key players in the Microbial Identification Market Focus on Agreements, Collaborations, Partnerships, and New Product Launches



Key players in the Microbial Identification Market Focus on Agreements, Collaborations, Partnerships, and New Product Launches


The prominent players in the microbial identification market include Becton, Dickinson and Company, (U.S.), Biolog Inc. (U.S.), bioMérieux SA (France), Bruker Corporation (U.S.), Charles River Laboratories Inc. (U.S.), MIDI Inc. (U.S.), QIAGEN N.V. (Netherlands), Shimadzu Corporation (Japan), Siemens Healthcare (Germany), Sigma-Aldrich Corporation (U.S.), and Thermo Fisher Scientific Inc. (U.S.).

bioMérieux SA (France) led the microbial identification products market, accounting for the highest share in 2013. The company has an exhaustive product portfolio that consists of various microbial identification products such as automated instruments, software database, and different consumables such as media, reagents, and kits. The company strategically focuses on innovations to improve its portfolio by adding new products to its existing line in order to create effective and enhanced utility to the products. For instance, in February 2014, the company launched VIDAS C. difficile GDH, an automated instrument for the detection, diagnosis, and treatment of infections caused by glutamate dehydrogenase. The company focuses on developing trending instruments for microbial identification and was one of the pioneers that used applications of MALDI TOF mass spectrometry in microbial identification and developed a product on it. In May 2010, bioMérieux entered into a strategic partnership with Shimadzu Corporation (Japan), to commercialize a mass spectrometry system for bacterial identification in microbiology laboratories. Moreover, in September 2012, the company launched VITEK MS, a revolutionary product for microbial identification. The company has a wide geographical presence and operates in over 150 countries across North America, Europe, Middle East, Africa, and Asia-Pacific.

The key strategies followed by most companies in the microbial identification market are agreements, collaborations, and partnerships; new product launches; acquisitions; approvals; and expansions. Agreements, collaborations, and partnerships accounted for the largest share of the overall growth strategies mapped from 2011 to 2014. The prominent players who adopted this strategy include Becton, Dickinson and Company, (U.S.), Biolog Inc. (U.S.), Bruker Corporation (U.S.), Charles River Laboratories Inc. (U.S.), QIAGEN N.V. (Netherlands), Siemens Healthcare (Germany), and Thermo Fisher Scientific Inc. (U.S.).
New product launches accounted for the second largest share of the overall growth strategies adopted by players in this market.

Related Reports:

Microbial Identification Market by Products (Consumables, Instruments, Services), Methods (Phenotypic, Genotypic), Application (Pharmaceutical, Diagnostic, Environmental, Food & Beverages) & by End User (Detection, Characterization) - Global Forecasts to 2019

Contact:
Mr. Rohan
North - Dominion Plaza,
17304 Preston Road,
Suite 800, Dallas, TX 75252
Tel: +1-888-600-6441
Email: sales@marketsandmarkets.com

Connect Us

Follow us on LinkedIn  Follow us on Facebook   Follow us on Twitter 
Live Chat Support


US : 1-888-600-6441

Search reports